Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBP) Assets Average (2016 - 2025)

Historic Assets Average for Regen BioPharma (RGBP) over the last 12 years, with Q4 2025 value amounting to $255852.0.

  • Regen BioPharma's Assets Average rose 4516.43% to $255852.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $255852.0, marking a year-over-year increase of 4516.43%. This contributed to the annual value of $217856.0 for FY2025, which is 1534.66% down from last year.
  • As of Q4 2025, Regen BioPharma's Assets Average stood at $255852.0, which was up 4516.43% from $235734.5 recorded in Q3 2025.
  • Over the past 5 years, Regen BioPharma's Assets Average peaked at $1.3 million during Q3 2021, and registered a low of $150149.0 during Q1 2024.
  • Over the past 5 years, Regen BioPharma's median Assets Average value was $287989.5 (recorded in 2023), while the average stood at $427793.4.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 110996.37% in 2021, then crashed by 6341.14% in 2024.
  • Regen BioPharma's Assets Average (Quarter) stood at $973670.0 in 2021, then crashed by 50.03% to $486555.0 in 2022, then plummeted by 47.27% to $256572.5 in 2023, then plummeted by 31.31% to $176250.0 in 2024, then surged by 45.16% to $255852.0 in 2025.
  • Its Assets Average stands at $255852.0 for Q4 2025, versus $235734.5 for Q3 2025 and $183161.5 for Q2 2025.